Vanguard Group Inc
- SEC CIK
- 0000102909
- Latest filing
- Jan 29, 2026
PLX holding history
Protalix BioTherapeutics, Inc. in every 13F filed by Vanguard Group Inc, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
PLX overviewAll 13F holders of PLXFull Q4 2025 holdings
- Shares (Q4 2025)
- 488,552
- Value
- $879.4K
- % of portfolio
- <0.1%
- Quarters held
- 7
- Since Q2 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2025 | 488,552 | $879.4K | <0.1% | +24,131+5.2% | Added | Holders |
| Q3 2025 | 464,421 | $1.03M | <0.1% | −20,377−4.2% | Reduced | Holders |
| Q2 2025 | 484,798 | $717.5K | <0.1% | +484,798 | New | Holders |
| Q2 2024 | 0 | $0 | 0.0% | −330,047−100.0% | Sold out | Holders |
| Q1 2024 | 330,047 | $415.9K | <0.1% | +27,361+9.0% | Added | Holders |
| Q4 2023 | 302,686 | $538.8K | <0.1% | +21,308+7.6% | Added | Holders |
| Q3 2023 | 281,378 | $467.1K | <0.1% | +51,041+22.2% | Added | Holders |
| Q2 2023 | 230,337 | $460.7K | <0.1% | +230,337 | New | Holders |